0	0	2000-09-21	CD	O	O	B-Num
0	1	19	CD	O	O	B-Num
0	2	:	:	O	O	I-Num
0	3	08	CD	O	B-NP	I-Num
0	4	BOSTON	NNP	O	I-NP	O
0	5	RESEARCHERS	NNS	O	I-NP	B-ProfTitle
0	6	UNRAVEL	NNP	O	I-NP	O
0	7	BRAIN	NNP	O	I-NP	O
0	8	'S	VBZ	O	B-VP	O
0	9	ROLE	NNP	O	B-NP	O
0	10	IN	IN	O	B-PP	O
0	11	DIABETES	NNP	O	B-NP	O

1	0	BOSTON	NNP	O	B-NP	O
1	1	_	NN	O	I-NP	O
1	2	Challenging	VBG	O	B-VP	O
1	3	long-held	JJ	O	B-NP	O
1	4	ideas	NNS	O	I-NP	O
1	5	about	IN	O	B-PP	O
1	6	how	WRB	O	O	O
1	7	diabetes	NN	O	B-NP	B-Medical
1	8	develops	VBZ	O	B-VP	O
1	9	COMMA	COMMA	O	O	O
1	10	researchers	NNS	O	B-NP	B-ProfTitle
1	11	at	IN	O	B-PP	O
1	12	the	DT	O	B-NP	O
1	13	Joslin	NNP	O	I-NP	B-Org
1	14	Diabetes	NNP	O	I-NP	I-Org
1	15	Center	NNP	O	I-NP	I-Org
1	16	have	VBP	O	B-VP	O
1	17	discovered	VBN	O	I-VP	O
1	18	that	IN	O	O	O
1	19	the	DT	O	B-NP	O
1	20	brain	NN	O	I-NP	O
1	21	is	VBZ	O	B-VP	O
1	22	an	DT	O	B-NP	O
1	23	important	JJ	O	I-NP	O
1	24	arena	NN	O	I-NP	O
1	25	for	IN	O	B-PP	O
1	26	insulin	NN	O	B-NP	O
1	27	's	POS	O	B-NP	O
1	28	action	NN	O	I-NP	O
1	29	in	IN	O	B-PP	O
1	30	controlling	VBG	O	B-VP	O
1	31	body	NN	O	B-NP	O
1	32	weight	NN	O	I-NP	O
1	33	COMMA	COMMA	O	O	O
1	34	appetite	NN	O	B-NP	O
1	35	COMMA	COMMA	O	O	O
1	36	and	CC	O	O	O
1	37	fertility	NN	O	B-NP	B-Medical
1	38	_	NN	O	I-NP	O
1	39	all	DT	O	B-NP	O
1	40	key	JJ	O	I-NP	O
1	41	factors	NNS	O	I-NP	O
1	42	in	IN	O	B-PP	O
1	43	the	DT	O	B-NP	O
1	44	epidemic	NN	O	I-NP	B-Medical
1	45	illness	NN	O	I-NP	O
1	46	affecting	VBG	O	B-VP	O
1	47	millions	NNS	O	B-NP	B-Num
1	48	of	IN	O	B-PP	O
1	49	Americans	NNPS	O	B-NP	B-LangRace
1	50	.	.	O	O	O

2	0	The	DT	O	B-NP	O
2	1	discovery	NN	O	I-NP	O
2	2	COMMA	COMMA	O	O	O
2	3	being	VBG	O	B-VP	O
2	4	reported	VBN	O	I-VP	O
2	5	Friday	NNP	O	B-NP	B-Date
2	6	COMMA	COMMA	O	O	O
2	7	is	VBZ	O	B-VP	O
2	8	among	IN	O	B-PP	O
2	9	several	JJ	O	B-NP	O
2	10	recent	JJ	O	I-NP	O
2	11	and	CC	O	I-NP	O
2	12	forthcoming	JJ	O	I-NP	O
2	13	findings	NNS	O	I-NP	O
2	14	that	WDT	O	B-NP	O
2	15	may	MD	O	B-VP	O
2	16	be	VB	O	I-VP	O
2	17	cracking	VBG	O	I-VP	O
2	18	open	JJ	O	O	O
2	19	the	DT	O	B-NP	O
2	20	riddle	NN	O	I-NP	O
2	21	of	IN	O	B-PP	O
2	22	diabetes	NN	O	B-NP	B-Medical
2	23	by	IN	O	B-PP	O
2	24	probing	VBG	O	B-VP	O
2	25	it	PRP	O	B-NP	O
2	26	at	IN	O	B-PP	O
2	27	the	DT	O	B-NP	O
2	28	level	NN	O	I-NP	O
2	29	of	IN	O	B-PP	O
2	30	genes	NNS	O	B-NP	O
2	31	and	CC	O	I-NP	O
2	32	proteins	NNS	O	I-NP	O
2	33	.	.	O	O	O

3	0	Diabetics	NNS	O	B-NP	O
3	1	'	POS	O	B-NP	O
3	2	bodies	NNS	O	I-NP	O
3	3	produce	VBP	O	B-VP	O
3	4	inadequate	JJ	O	B-NP	O
3	5	insulin	NN	O	I-NP	O
3	6	COMMA	COMMA	O	O	O
3	7	the	DT	O	B-NP	O
3	8	hormone	NN	O	I-NP	B-Medical
3	9	that	WDT	O	B-NP	O
3	10	regulates	VBZ	O	B-VP	O
3	11	the	DT	O	B-NP	O
3	12	conversion	NN	O	I-NP	O
3	13	of	IN	O	B-PP	O
3	14	blood-sugar	NN	O	B-NP	O
3	15	into	IN	O	B-PP	O
3	16	energy	NN	O	B-NP	O
3	17	to	TO	O	B-PP	O
3	18	fuel	NN	O	B-NP	O
3	19	activity	NN	O	I-NP	O
3	20	.	.	O	O	O

4	0	The	DT	O	B-NP	O
4	1	Joslin	NNP	O	I-NP	O
4	2	researchers	NNS	O	I-NP	B-ProfTitle
4	3	COMMA	COMMA	O	O	O
4	4	led	VBN	O	B-VP	O
4	5	by	IN	O	B-PP	O
4	6	Dr.	NNP	O	B-NP	B-ProfTitle
4	7	C.	NNP	O	I-NP	O
4	8	Ronald	NNP	O	I-NP	B-Peop
4	9	Kahn	NNP	O	I-NP	I-Peop
4	10	COMMA	COMMA	O	O	O
4	11	president	NN	O	B-NP	B-ProfTitle
4	12	&	CC	O	O	O
4	13	UR	NNP	O	B-NP	O
4	14	;	:	O	O	O
4	15	&	CC	O	O	O
4	16	LR	NNP	O	B-NP	O
4	17	;	:	O	O	O
4	18	of	IN	O	B-PP	O
4	19	the	DT	O	B-NP	O
4	20	renowned	JJ	O	I-NP	O
4	21	center	NN	O	I-NP	O
4	22	COMMA	COMMA	O	O	O
4	23	showed	VBD	O	B-VP	O
4	24	that	IN	O	O	O
4	25	blocking	VBG	O	B-VP	O
4	26	the	DT	O	B-NP	O
4	27	effects	NNS	O	I-NP	O
4	28	of	IN	O	B-PP	O
4	29	insulin	NN	O	B-NP	O
4	30	in	IN	O	B-PP	B-Medical
4	31	the	DT	O	B-NP	I-Medical
4	32	brain	NN	O	I-NP	I-Medical
4	33	caused	VBD	O	B-VP	O
4	34	mice	NNS	O	B-NP	B-Animal
4	35	to	TO	O	B-PP	O
4	36	overeat	NN	O	B-NP	O
4	37	COMMA	COMMA	O	I-NP	O
4	38	gain	NN	O	I-NP	O
4	39	weight	NN	O	I-NP	O
4	40	COMMA	COMMA	O	O	O
4	41	not	RB	O	O	O
4	42	respond	VBP	O	B-VP	O
4	43	properly	RB	O	O	O
4	44	to	TO	O	B-PP	O
4	45	insulin	NN	O	B-NP	O
4	46	elsewhere	RB	O	O	O
4	47	in	IN	O	B-PP	B-Medical
4	48	the	DT	O	B-NP	I-Medical
4	49	body	NN	O	I-NP	I-Medical
4	50	COMMA	COMMA	O	O	O
4	51	and	CC	O	O	O
4	52	to	TO	O	B-VP	O
4	53	produce	VB	O	I-VP	O
4	54	fewer	JJR	O	B-NP	O
4	55	offspring	NN	O	I-NP	O
4	56	.	.	O	O	O

5	0	These	DT	O	B-NP	O
5	1	are	VBP	O	B-VP	O
5	2	all	DT	O	B-NP	O
5	3	conditions	NNS	O	I-NP	O
5	4	that	IN	O	B-NP	O
5	5	occur	VBP	O	B-VP	O
5	6	in	IN	O	B-PP	O
5	7	Type	NNP	O	B-NP	B-Loc
5	8	2	CD	O	I-NP	B-Num
5	9	diabetes	NN	O	I-NP	B-Medical
5	10	COMMA	COMMA	O	O	O
5	11	the	DT	O	B-NP	O
5	12	form	NN	O	I-NP	O
5	13	that	WDT	O	B-NP	O
5	14	is	VBZ	O	B-VP	O
5	15	usually	RB	O	O	O
5	16	-LBR-	-LBR-	O	O	O
5	17	but	CC	O	O	O
5	18	not	RB	O	O	O
5	19	always	RB	O	O	O
5	20	-RBR-	-RBR-	O	O	O
5	21	diagnosed	VBD	O	B-VP	O
5	22	in	IN	O	B-PP	O
5	23	adults	NNS	O	B-NP	O
5	24	and	CC	O	O	O
5	25	is	VBZ	O	B-VP	O
5	26	associated	VBN	O	I-VP	O
5	27	with	IN	O	B-PP	O
5	28	obesity	NN	O	B-NP	B-Medical
5	29	.	.	O	O	O

6	0	The	DT	O	B-NP	O
6	1	only	JJ	O	I-NP	O
6	2	way	NN	O	I-NP	O
6	3	in	IN	O	B-PP	O
6	4	which	WDT	O	B-NP	O
6	5	the	DT	O	B-NP	O
6	6	mice	NNS	O	I-NP	B-Animal
6	7	weren	NN	O	I-NP	O
6	8	't	NN	O	I-NP	O
6	9	like	IN	O	B-PP	O
6	10	diabetic	JJ	O	B-NP	O
6	11	mice	NNS	O	I-NP	B-Animal
6	12	was	VBD	O	B-VP	O
6	13	that	IN	O	O	O
6	14	they	PRP	O	B-NP	O
6	15	didn	NN	O	B-NP	O
6	16	't	NN	O	I-NP	O
6	17	have	VBP	O	B-VP	O
6	18	high	JJ	O	B-NP	B-Medical
6	19	blood	NN	O	I-NP	I-Medical
6	20	sugar	NN	O	I-NP	I-Medical
6	21	COMMA	COMMA	O	O	O
6	22	said	VBD	O	B-VP	O
6	23	Kahn	NNP	O	B-NP	B-Peop
6	24	in	IN	O	B-PP	O
6	25	an	DT	O	B-NP	O
6	26	interview	NN	O	I-NP	O
6	27	.	.	O	O	O

7	0	Kahn	NNP	O	B-NP	B-Peop
7	1	and	CC	O	O	O
7	2	his	PP$	O	B-NP	O
7	3	colleagues	NNS	O	I-NP	O
7	4	COMMA	COMMA	O	O	O
7	5	writing	VBG	O	B-VP	O
7	6	in	IN	O	B-PP	O
7	7	the	DT	O	B-NP	O
7	8	journal	NN	O	I-NP	B-Jour
7	9	Science	NNP	O	B-NP	O
7	10	COMMA	COMMA	O	O	O
7	11	said	VBD	O	B-VP	O
7	12	they	PRP	O	B-NP	O
7	13	created	VBD	O	B-VP	O
7	14	bioengineered	JJ	O	B-NP	O
7	15	mice	NNS	O	I-NP	B-Animal
7	16	whose	WP$	O	B-NP	O
7	17	brain	NN	O	I-NP	O
7	18	cells	NNS	O	I-NP	O
7	19	lacked	VBD	O	B-VP	O
7	20	insulin	NN	O	B-NP	O
7	21	receptors	NNS	O	I-NP	O
7	22	_	NN	O	I-NP	O
7	23	structures	NNS	O	I-NP	O
7	24	that	IN	O	B-PP	O
7	25	insulin	NN	O	B-NP	O
7	26	molecules	NNS	O	I-NP	B-Jour
7	27	normally	RB	O	O	O
7	28	bind	VBP	O	B-VP	O
7	29	to	TO	O	I-VP	O
7	30	COMMA	COMMA	O	O	O
7	31	like	IN	O	B-PP	O
7	32	a	DT	O	B-NP	O
7	33	key	NN	O	I-NP	O
7	34	entering	VBG	O	B-VP	O
7	35	a	DT	O	B-NP	O
7	36	lock	NN	O	I-NP	O
7	37	.	.	O	O	O

8	0	With	IN	O	B-PP	O
8	1	the	DT	O	B-NP	O
8	2	receptors	NNS	O	I-NP	O
8	3	absent	JJ	O	I-NP	O
8	4	COMMA	COMMA	O	I-NP	O
8	5	insulin	NN	O	I-NP	O
8	6	wouldn	NN	O	I-NP	O
8	7	't	NN	O	I-NP	O
8	8	be	VB	O	B-VP	O
8	9	active	JJ	O	O	O
8	10	in	IN	O	B-PP	B-Medical
8	11	the	DT	O	B-NP	I-Medical
8	12	brain	NN	O	I-NP	I-Medical
8	13	COMMA	COMMA	O	O	O
8	14	but	CC	O	O	O
8	15	the	DT	O	B-NP	O
8	16	scientists	NNS	O	I-NP	B-ProfTitle
8	17	didn	NN	O	I-NP	O
8	18	't	NN	O	I-NP	O
8	19	know	VB	O	B-VP	O
8	20	what	WP	O	B-NP	O
8	21	the	DT	O	B-NP	O
8	22	consequences	NNS	O	I-NP	O
8	23	would	MD	O	B-VP	O
8	24	be	VB	O	I-VP	O
8	25	.	.	O	O	O

9	0	``	``	O	O	O
9	1	I	PRP	O	B-NP	O
9	2	think	VBP	O	B-VP	O
9	3	most	JJS	O	B-NP	O
9	4	people	NNS	O	I-NP	O
9	5	thought	VBD	O	B-VP	O
9	6	that	IN	O	O	O
9	7	if	IN	O	O	O
9	8	insulin	NN	O	B-NP	O
9	9	and	CC	O	O	O
9	10	the	DT	O	B-NP	O
9	11	insulin	NN	O	I-NP	O
9	12	receptors	NNS	O	I-NP	O
9	13	had	VBD	O	B-VP	O
9	14	any	DT	O	B-NP	O
9	15	function	NN	O	I-NP	O
9	16	at	IN	O	B-PP	O
9	17	all	DT	O	O	O
9	18	COMMA	COMMA	O	O	O
9	19	it	PRP	O	B-NP	O
9	20	would	MD	O	B-VP	O
9	21	be	VB	O	I-VP	O
9	22	in	IN	O	B-PP	O
9	23	the	DT	O	B-NP	O
9	24	development	NN	O	I-NP	O
9	25	of	IN	O	B-PP	O
9	26	the	DT	O	B-NP	O
9	27	brainCOMMA	NN	O	I-NP	O
9	28	''	''	O	O	O
9	29	Kahn	NNP	O	B-NP	B-Peop
9	30	said	VBD	O	B-VP	O
9	31	.	.	O	O	O

10	0	But	CC	O	O	O
10	1	in	IN	O	B-PP	O
10	2	fact	NN	O	B-NP	O
10	3	COMMA	COMMA	O	O	O
10	4	the	DT	O	B-NP	O
10	5	brains	NNS	O	I-NP	O
10	6	of	IN	O	B-PP	O
10	7	the	DT	O	B-NP	O
10	8	mice	NNS	O	I-NP	B-Animal
10	9	developed	VBD	O	B-VP	O
10	10	normally	RB	O	O	O
10	11	.	.	O	O	O

11	0	To	TO	O	B-PP	O
11	1	their	PP$	O	B-NP	O
11	2	surprise	NN	O	I-NP	O
11	3	the	DT	O	B-NP	O
11	4	scientists	NNS	O	I-NP	B-ProfTitle
11	5	found	VBD	O	B-VP	O
11	6	that	IN	O	O	O
11	7	the	DT	O	B-NP	O
11	8	modified	VBN	O	I-NP	O
11	9	mice	NNS	O	I-NP	B-Animal
11	10	showed	VBD	O	B-VP	O
11	11	many	JJ	O	B-NP	O
11	12	features	NNS	O	I-NP	O
11	13	of	IN	O	B-PP	O
11	14	diabetes	NN	O	B-NP	B-Medical
11	15	.	.	O	O	O

12	0	The	DT	O	B-NP	O
12	1	females	NNS	O	I-NP	O
12	2	ate	VBD	O	B-VP	O
12	3	more	RBR	O	O	O
12	4	and	CC	O	O	O
12	5	got	VBD	O	B-VP	O
12	6	fatter	JJR	O	O	O
12	7	even	RB	O	O	O
12	8	on	IN	O	B-PP	O
12	9	a	DT	O	B-NP	O
12	10	normal	JJ	O	I-NP	O
12	11	diet	NN	O	I-NP	O
12	12	COMMA	COMMA	O	O	O
12	13	while	IN	O	O	O
12	14	the	DT	O	B-NP	O
12	15	males	NNS	O	I-NP	O
12	16	and	CC	O	I-NP	O
12	17	females	NNS	O	I-NP	O
12	18	both	DT	O	O	O
12	19	gained	VBD	O	B-VP	O
12	20	weight	NN	O	B-NP	O
12	21	on	IN	O	B-PP	O
12	22	a	DT	O	B-NP	O
12	23	high-fat	JJ	O	I-NP	O
12	24	diet	NN	O	I-NP	O
12	25	.	.	O	O	O

13	0	The	DT	O	B-NP	O
13	1	mice	NNS	O	I-NP	B-Animal
13	2	's	POS	O	B-NP	O
13	3	blood	NN	O	I-NP	O
13	4	also	RB	O	O	O
13	5	contained	VBD	O	O	O
13	6	more	RBR	O	O	O
13	7	leptin	NN	O	O	O
13	8	than	IN	O	B-PP	O
13	9	normal	JJ	O	O	O
13	10	:	:	O	O	O
13	11	leptin	NN	O	B-NP	O
13	12	is	VBZ	O	B-VP	O
13	13	a	DT	O	B-NP	O
13	14	signaling	VBG	O	I-NP	O
13	15	molecule	NN	O	I-NP	O
13	16	that	WDT	O	B-NP	O
13	17	helps	VBZ	O	B-VP	O
13	18	regulate	VB	O	I-VP	O
13	19	appetite	NN	O	B-NP	O
13	20	COMMA	COMMA	O	O	O
13	21	but	CC	O	O	O
13	22	it	PRP	O	B-NP	O
13	23	didn	NN	O	B-NP	O
13	24	't	NN	O	I-NP	O
13	25	seem	VBP	O	B-VP	O
13	26	very	RB	O	O	O
13	27	effective	JJ	O	O	O
13	28	in	IN	O	B-PP	O
13	29	these	DT	O	B-NP	O
13	30	mice	NNS	O	I-NP	B-Animal
13	31	.	.	O	O	O

14	0	And	CC	O	O	O
14	1	the	DT	O	B-NP	O
14	2	mice	NNS	O	I-NP	B-Animal
14	3	had	VBD	O	B-VP	O
14	4	reduced	VBN	O	I-VP	O
14	5	fertility	NN	O	B-NP	B-Medical
14	6	because	IN	O	O	O
14	7	sperm	NN	O	B-NP	O
14	8	and	CC	O	I-NP	O
14	9	egg	NN	O	I-NP	B-Food
14	10	production	NN	O	I-NP	O
14	11	was	VBD	O	B-VP	O
14	12	abnormal	JJ	O	O	O
14	13	.	.	O	O	O

15	0	Also	RB	O	O	O
15	1	COMMA	COMMA	O	O	O
15	2	the	DT	O	B-NP	O
15	3	female	JJ	O	I-NP	O
15	4	mice	NNS	O	I-NP	B-Animal
15	5	exhibited	VBD	O	B-VP	O
15	6	insulin	NN	O	B-NP	O
15	7	resistance	NN	O	I-NP	O
15	8	:	:	O	O	O
15	9	that	DT	O	B-NP	O
15	10	is	VBZ	O	B-VP	O
15	11	COMMA	COMMA	O	O	O
15	12	doses	NNS	O	B-NP	O
15	13	of	IN	O	B-PP	O
15	14	insulin	NN	O	B-NP	O
15	15	injected	VBD	O	B-VP	O
15	16	into	IN	O	B-PP	O
15	17	them	PRP	O	B-NP	O
15	18	failed	VBD	O	B-VP	O
15	19	to	TO	O	I-VP	O
15	20	stop	VB	O	I-VP	O
15	21	a	DT	O	B-NP	O
15	22	rise	NN	O	I-NP	O
15	23	in	IN	O	B-PP	O
15	24	blood	NN	O	B-NP	O
15	25	sugar	NN	O	I-NP	O
15	26	after	IN	O	O	O
15	27	they	PRP	O	B-NP	O
15	28	had	VBD	O	B-VP	O
15	29	eaten	VBN	O	I-VP	O
15	30	.	.	O	O	O

16	0	The	DT	O	B-NP	O
16	1	findings	NNS	O	I-NP	O
16	2	COMMA	COMMA	O	O	O
16	3	Kahn	NNP	O	B-NP	B-Peop
16	4	said	VBD	O	B-VP	O
16	5	COMMA	COMMA	O	O	O
16	6	``	``	O	O	O
16	7	force	VBP	O	B-VP	O
16	8	us	PRP	O	B-NP	O
16	9	to	TO	O	B-VP	O
16	10	open	VB	O	I-VP	O
16	11	our	PP$	O	B-NP	O
16	12	minds	NNS	O	I-NP	O
16	13	to	TO	O	B-PP	O
16	14	the	DT	O	B-NP	O
16	15	idea	NN	O	I-NP	O
16	16	that	IN	O	O	O
16	17	insulin	NN	O	B-NP	O
16	18	action	NN	O	I-NP	O
16	19	and	CC	O	I-NP	O
16	20	resistance	NN	O	I-NP	O
16	21	in	IN	O	B-PP	B-Medical
16	22	the	DT	O	B-NP	I-Medical
16	23	brain	NN	O	I-NP	I-Medical
16	24	contribute	VB	O	B-VP	O
16	25	in	IN	O	B-PP	O
16	26	some	DT	O	B-NP	O
16	27	way	NN	O	I-NP	O
16	28	''	''	O	O	O
16	29	to	TO	O	B-PP	O
16	30	the	DT	O	B-NP	O
16	31	development	NN	O	I-NP	O
16	32	of	IN	O	B-PP	O
16	33	diabetes	NN	O	B-NP	B-Medical
16	34	.	.	O	O	O

17	0	It	PRP	O	B-NP	O
17	1	doesn	NN	O	B-NP	O
17	2	't	NN	O	I-NP	O
17	3	mean	VBP	O	B-VP	O
17	4	COMMA	COMMA	O	O	O
17	5	he	PRP	O	B-NP	O
17	6	said	VBD	O	B-VP	O
17	7	COMMA	COMMA	O	O	O
17	8	that	DT	O	B-NP	O
17	9	most	JJS	O	I-NP	O
17	10	human	JJ	O	I-NP	B-Animal
17	11	diabetics	NNS	O	I-NP	O
17	12	have	VBP	O	B-VP	O
17	13	a	DT	O	B-NP	O
17	14	damaged	VBN	O	I-NP	O
17	15	insulin	NN	O	I-NP	O
17	16	receptor	NN	O	I-NP	O
17	17	in	IN	O	B-PP	B-Medical
17	18	the	DT	O	B-NP	I-Medical
17	19	brain	NN	O	I-NP	I-Medical
17	20	_	NN	O	I-NP	O
17	21	that	DT	O	B-NP	O
17	22	was	VBD	O	B-VP	O
17	23	just	RB	O	B-NP	O
17	24	a	DT	O	I-NP	O
17	25	tool	NN	O	I-NP	O
17	26	to	TO	O	B-VP	O
17	27	help	VB	O	I-VP	O
17	28	determine	VB	O	I-VP	O
17	29	what	WP	O	B-NP	O
17	30	insulin	NN	O	I-NP	O
17	31	COMMA	COMMA	O	O	O
17	32	a	DT	O	B-NP	O
17	33	hormone	NN	O	I-NP	B-Medical
17	34	COMMA	COMMA	O	O	O
17	35	normally	RB	O	O	O
17	36	does	VBZ	O	B-VP	O
17	37	.	.	O	O	O

18	0	Federal	NNP	O	B-NP	O
18	1	officials	NNS	O	I-NP	O
18	2	recently	RB	O	O	O
18	3	reported	VBD	O	B-VP	O
18	4	that	IN	O	O	O
18	5	the	DT	O	B-NP	O
18	6	prevalence	NN	O	I-NP	O
18	7	of	IN	O	B-PP	O
18	8	Type	NNP	O	B-NP	O
18	9	2	CD	O	I-NP	B-Num
18	10	diabetes	NN	O	I-NP	B-Medical
18	11	has	VBZ	O	B-VP	O
18	12	risen	VBN	O	I-VP	O
18	13	by	IN	O	B-PP	O
18	14	one-third	NN	O	B-NP	O
18	15	during	IN	O	B-PP	O
18	16	the	DT	O	B-NP	O
18	17	last	JJ	O	I-NP	O
18	18	decade	NN	O	I-NP	O
18	19	COMMA	COMMA	O	O	O
18	20	an	DT	O	B-NP	O
18	21	alarming	JJ	O	I-NP	O
18	22	discovery	NN	O	I-NP	O
18	23	that	IN	O	B-NP	O
18	24	's	POS	O	B-VP	O
18	25	blamed	VBD	O	B-VP	O
18	26	mainly	RB	O	O	O
18	27	on	IN	O	B-PP	O
18	28	obesity	NN	O	B-NP	B-Medical
18	29	and	CC	O	I-NP	O
18	30	inactivity	NN	O	I-NP	O
18	31	COMMA	COMMA	O	O	O
18	32	especially	RB	O	O	O
18	33	in	IN	O	B-PP	O
18	34	young	JJ	O	B-NP	O
18	35	people	NNS	O	I-NP	O
18	36	.	.	O	O	O

19	0	Type	NNP	O	B-NP	O
19	1	1	CD	O	I-NP	B-Num
19	2	diabetes	NN	O	I-NP	B-Medical
19	3	is	VBZ	O	B-VP	O
19	4	the	DT	O	B-NP	O
19	5	form	NN	O	I-NP	O
19	6	that	WDT	O	B-NP	O
19	7	usually	RB	O	O	O
19	8	appears	VBZ	O	B-VP	O
19	9	early	JJ	O	O	O
19	10	in	IN	O	B-PP	O
19	11	life	NN	O	B-NP	O
19	12	and	CC	O	O	O
19	13	patients	NNS	O	B-NP	O
19	14	with	IN	O	B-PP	O
19	15	it	PRP	O	B-NP	O
19	16	frequently	RB	O	O	O
19	17	require	VBP	O	B-VP	O
19	18	insulin	NN	O	B-NP	O
19	19	shots	NNS	O	I-NP	O
19	20	.	.	O	O	O

20	0	Type	NNP	O	B-NP	O
20	1	2	CD	O	I-NP	B-Num
20	2	diabetes	NN	O	I-NP	B-Medical
20	3	COMMA	COMMA	O	O	O
20	4	much	RB	O	O	O
20	5	more	RBR	O	O	O
20	6	prevalent	JJ	O	O	O
20	7	COMMA	COMMA	O	O	O
20	8	can	MD	O	B-VP	O
20	9	often	RB	O	I-VP	O
20	10	be	VB	O	I-VP	O
20	11	treated	VBN	O	I-VP	O
20	12	with	IN	O	B-PP	O
20	13	diet	NN	O	B-NP	O
20	14	and	CC	O	I-NP	O
20	15	exercise	NN	O	I-NP	B-Sport
20	16	.	.	O	O	O

21	0	There	EX	O	B-NP	O
21	1	's	VBZ	O	B-VP	O
21	2	still	RB	O	O	O
21	3	much	JJ	O	O	O
21	4	that	IN	O	B-NP	O
21	5	's	POS	O	B-VP	O
21	6	not	RB	O	B-VP	O
21	7	understood	VBN	O	I-VP	O
21	8	about	IN	O	B-PP	O
21	9	the	DT	O	B-NP	O
21	10	immensely	RB	O	I-NP	O
21	11	complex	JJ	O	I-NP	O
21	12	system	NN	O	I-NP	O
21	13	in	IN	O	B-PP	B-Medical
21	14	the	DT	O	B-NP	I-Medical
21	15	body	NN	O	I-NP	I-Medical
21	16	that	DT	O	B-NP	O
21	17	regulates	VBZ	O	B-VP	O
21	18	how	WRB	O	O	O
21	19	food	NN	O	B-NP	B-Food
21	20	is	VBZ	O	B-VP	O
21	21	turned	VBN	O	I-VP	O
21	22	into	IN	O	B-PP	O
21	23	energy	NN	O	B-NP	O
21	24	COMMA	COMMA	O	O	O
21	25	and	CC	O	O	O
21	26	which	WDT	O	B-NP	O
21	27	goes	VBZ	O	B-VP	O
21	28	wrong	JJ	O	O	O
21	29	in	IN	O	B-PP	O
21	30	diabetes	NN	O	B-NP	B-Medical
21	31	.	.	O	O	O

22	0	Scientists	NNS	O	B-NP	B-ProfTitle
22	1	are	VBP	O	B-VP	O
22	2	beginning	VBG	O	I-VP	O
22	3	to	TO	O	I-VP	O
22	4	uncover	VB	O	I-VP	O
22	5	genes	NNS	O	B-NP	O
22	6	that	IN	O	B-NP	O
22	7	carry	VBP	O	B-VP	O
22	8	mutations	NNS	O	B-NP	O
22	9	which	WDT	O	B-NP	O
22	10	can	MD	O	B-VP	O
22	11	contribute	VB	O	I-VP	O
22	12	to	TO	O	B-PP	O
22	13	diabetes	NN	O	B-NP	B-Medical
22	14	.	.	O	O	O

23	0	``	``	O	O	O
23	1	These	DT	O	B-NP	O
23	2	insights	NNS	O	I-NP	O
23	3	will	MD	O	B-VP	O
23	4	put	VB	O	I-VP	O
23	5	us	PRP	O	B-NP	O
23	6	in	IN	O	B-PP	O
23	7	a	DT	O	B-NP	O
23	8	better	JJR	O	I-NP	O
23	9	position	NN	O	I-NP	O
23	10	the	DT	O	B-NP	O
23	11	development	NN	O	I-NP	O
23	12	of	IN	O	B-PP	O
23	13	diabetesCOMMA	NN	O	B-NP	O
23	14	''	''	O	O	O
23	15	Kahn	NNP	O	B-NP	B-Peop
23	16	said	VBD	O	B-VP	O
23	17	COMMA	COMMA	O	O	O
23	18	as	RB	O	O	O
23	19	well	RB	O	O	O
23	20	as	IN	O	O	O
23	21	to	TO	O	B-VP	O
23	22	provide	VB	O	I-VP	O
23	23	new	JJ	O	B-NP	O
23	24	targets	NNS	O	I-NP	O
23	25	for	IN	O	B-PP	O
23	26	drugs	NNS	O	B-NP	O
23	27	to	TO	O	B-VP	O
23	28	treat	VB	O	I-VP	O
23	29	the	DT	O	B-NP	O
23	30	disease	NN	O	I-NP	B-Medical
23	31	.	.	O	O	O
